Back
Sep 30
Education

EDU 58 - ASTRO/ISRS Joint Session: Rediscovering Indications for Non-tumor Stereotactic Radiosurgery (SRS)

05:15pm - 06:15pm PT

MODERATOR(S)

Louise Murray, MB, ChB, PhD - University of Leeds

session DESCRIPTION

Stereotactic Radiosurgery (SRS) has several applications that extend beyond its more recognized role in the management of selected patients with benign and malignant brain tumors. Such applications include the management of trigeminal neuralgia (TN), arteriovenous malformations (AVM) and obsessive-compulsive disorder (OCD). The use of SRS is non-tumor situations is relevant in both adult and pediatric populations, in particular in the management of arteriovenous malformations. There are, however, alternative interventions for all these non-tumor scenarios, and where SRS should "sit" in relation to other treatments, and at what point it should be considered, is not always clear. This session is designed to provide an overview of these non-tumor applications of SRS, including indications, technical approaches and evidence base, with reference to alternative treatment options. A Neurosurgeon, with extensive experience in multiple treatment approaches for trigeminal neuralgia, will talk about the role of SRS in this context. A Medical Physicist, with an active research interest in planning and treatment of arteriovenous malformations using SRS, will present on this. A Radiation Oncologist, with a wealth of experience in SRS for multiple tumor and non-tumor indications, will talk about the role of SRS in obsessive-compulsive disorder. Given the pan-age relevance of SRS for non-tumor indications, this session will be run jointly between the adult CNS and pediatric tracks. We are also delighted to run the session in association with the International Stereotactic Radiosurgery Society: ISRS.

learning objectives

  1. Identify patients for whom SRS would be appropriate for the management of non-tumor indications, in particular for trigeminal neuralgia, arteriovenous malformations and obsessive-compulsive disorder.
  2. Describe the technical aspects of SRS delivery for the above non-tumor indications.
  3. Discuss the evidence base to support the use of SRS delivery for the above non-tumour indications in the context of the other available treatment options.

Credits

AMA PRA Category 1 Credits: 1.00

Presentations